Latest Market News

Energy Action Limited reported positive operating cash flow for Q2 FY26 and secured a deferral on key loan repayments while investing in its AI-powered platform and appointing new board members.

PainChek has secured FDA-regulated medical device status, enabling US Remote Therapeutic Monitoring reimbursement and opening a major US growth avenue. The company targets musculoskeletal pain management in non-verbal dementia patients, a largely underserved market.

4DS Memory Limited reports steady progress in its strategic review focused on AI-related opportunities, alongside significant cost reductions and a solid cash position of $8.8 million at the end of December 2025.

Perpetual Limited’s second quarter FY26 update reveals a mixed performance with strong Corporate Trust growth balancing net outflows in Asset Management, while Wealth Management remains stable amid ongoing sale talks.

Temas Resources has confirmed its patented Regenerative Chloride Leach (RCL) technology can produce commercial-grade titanium dioxide with significant cost reductions, positioning the company for global licensing opportunities.

Wisr has reported a strong Q2FY26 performance, showcasing robust loan book growth and improved credit quality, while signalling a clear path to profitability in the second half of FY26.

Nova Eye Medical has reported a record US$6.1 million in global sales for the December 2025 quarter, marking a 38% year-on-year increase and strong momentum across key markets. The company’s innovative iTrack™ technology continues to drive growth, supported by expanded manufacturing capacity and advancing clinical programs.

AMP Limited has revised its cost allocation and cost-to-income ratio methodology, restating prior business unit profits and setting FY26 cost guidance between $630 million and $640 million.

Sea Forest Limited has exceeded its breakeven target for its methane-reducing feed additive SeaFeed™, securing commitments for over 118,000 cattle and expanding commercial trials with major industry partners.

NGX Limited has progressed its natural graphite exploration in Malawi and uranium projects in Namibia, while maintaining a robust financial footing with $2.7 million cash and no debt. The company is actively pursuing strategic partnerships and development pathways aligned with the clean energy transition.

Whitehaven Coal reported a strong December quarter with a 21% rise in production and improved metallurgical coal prices, underpinning a solid first half of FY26. The company also advanced key development projects while maintaining disciplined cost management.

Imricor Medical Systems has achieved a major milestone with FDA clearance for its NorthStar Mapping System, the first MRI-native 3D cardiac mapping platform approved in the US. This approval positions Imricor at the forefront of MRI-guided cardiac procedures in the world’s largest electrophysiology market.